Bacterial Infections  >>  Isentress (raltegravir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Isentress (raltegravir) / Merck (MSD)
RIFRAL, NCT01424826: The Effect of Intermittent Rifampicin on Raltegravir

Completed
1
18
Europe
Raltegravir, Rifampicin
Helen Reynolds, Liverpool University Hospitals NHS Foundation Trust
HIV, Tuberculosis
06/13
07/13

Download Options